Research study Program year 2023 Source: CMS Open Payments

Rm-493-014/Rm-493-022

Research payments

$212,491

6 payments

Through program year 2023, $212,491 in research payments was reported against Rm-493-014/Rm-493-022, across 6 payments, paid by Rhythm Pharmaceuticals, Inc..

Paid by: Rhythm Pharmaceuticals, Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

2 rows

Year	Kind	Amount	Payments
2023	Research	$5,605	1
2022	Research	$206,886	5

Breakdown

Who paid Research payments · program years 2022–2023

Rhythm Pharmaceuticals, Inc. $212,491 6 payments

Who received the money Research payments · program years 2022–2023

Geisinger Clinic Organisation paid for research $100,955 2 payments
Marshfield Clinic Foundation Organisation paid for research $83,181 1 payment
University Of Florida College Of Medicine Organisation paid for research $15,925 1 payment
Duke University Organisation paid for research $6,825 1 payment
Synexus Clinical Research US, Inc. Organisation paid for research $5,605 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

5 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.